Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share (EPS) estimates for Acadia Healthcare in a report released on Wednesday, May 14th. Leerink Partnrs analyst W. Mayo expects that the company will earn $0.61 per share for the quarter. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare's Q3 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.79 EPS, Q1 2026 earnings at $0.49 EPS, Q2 2026 earnings at $0.72 EPS, Q3 2026 earnings at $0.87 EPS, FY2026 earnings at $2.91 EPS and FY2027 earnings at $3.32 EPS.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same quarter in the prior year, the firm posted $0.84 earnings per share. The company's quarterly revenue was up .3% on a year-over-year basis.
Other equities research analysts have also issued research reports about the company. Bank of America dropped their price target on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Guggenheim started coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price target on the stock. Royal Bank of Canada dropped their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Mizuho dropped their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Finally, Barclays dropped their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $47.94.
View Our Latest Research Report on Acadia Healthcare
Acadia Healthcare Trading Down 1.9%
NASDAQ:ACHC traded down $0.43 during mid-day trading on Monday, hitting $22.53. The company had a trading volume of 1,532,977 shares, compared to its average volume of 1,717,908. The firm has a market cap of $2.08 billion, a P/E ratio of 7.39, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The business's fifty day moving average is $25.70 and its two-hundred day moving average is $34.95. Acadia Healthcare has a fifty-two week low of $20.36 and a fifty-two week high of $82.41.
Institutional Investors Weigh In On Acadia Healthcare
Hedge funds and other institutional investors have recently bought and sold shares of the company. Lindbrook Capital LLC raised its position in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after buying an additional 671 shares during the last quarter. Blue Trust Inc. raised its position in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC grew its stake in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after purchasing an additional 1,004 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its stake in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after purchasing an additional 1,234 shares in the last quarter.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
